SEC FCPA Enforcement Settlement with Astra Zeneca PLC Requires Payment of $5.5 Million

IMPORTANT: The full content of this page is available to premium users only.

Friday, September 9, 2016

Author:

Bruce Zagaris

Volume:

32

Issue:

9

Abstract:

On August 31, 2016, the Securities and Exchange Commission and AstraZeneca PLC (AZN) entered into a settlement of SEC’s allegations of violating internal controls and recordkeeping provisions of the Foreign Corrupt Practices Act (FCPA) by AZN and its wholly owned-subsidiaries in China and Russia. AstraZeneca PLC must pay a disgorgement of $4,325,000, which represents profits gained as a result of the violations, prejudgment interest of $822,000, and a civil money penalty of $375,000.